This article was originally published in The Gray Sheet
FDA posts Mentor and Inamed saline breast implant five-year labeling data on its website. The firms presented the updated data at a July 9 meeting of the agency's General and Plastic Surgery Devices Panel (1"The Gray Sheet" July 15, 2002, p. 3). Inamed showed a re-operation rate of 26% for augmentation patients and 44.5% for reconstruction patients, while Mentor re-operation rates were 20% and 43%, respectively...
You may also be interested in...
Mentor and Inamed should reconvene focus groups to review patient labeling changes for saline-filled breast implants, FDA's General and Plastic Surgery Devices Panel recommended July 9 at its meeting in Gaithersburg, Maryland
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.